Security key
63009J107
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 46,821,220
- Total 13F shares
- 9,306,982
- Share change
- +35,576
- Total reported value
- $59,748,622
- Price per share
- $6.50
- Number of holders
- 11
- Value change
- +$230,299
- Number of buys
- 5
- Number of sells
- 3
Report period
Q1 2024
Institutions
11
Top holders
10
NBTX full security history
Newer quarter: Q2 2024
Previous quarter: Q4 2023
Nanobiotix S.A. SEC filings
Nanobiotix S.A. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 63009J107
Recent filing periods:
Top shareholders of NBTX - Nanobiotix S.A. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Invus Global Management, LLC |
13D/G
|
Invus Public Equities, L.P. |
8.9%
|
4,232,829
|
$13,545,053 | $0 | 31 Dec 2023 | |
| JOHNSON & JOHNSON |
13F
|
Company |
12%
|
5,623,816
|
$40,941,380 | — | 31 Dec 2023 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
6.1%
|
2,869,030
|
$20,886,539 | — | 31 Dec 2023 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.2%
|
555,066
|
$4,040,880 | — | 31 Dec 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.47%
|
218,515
|
$1,590,789 | — | 31 Dec 2023 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
3,100
|
$22,568 | — | 31 Dec 2023 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
635
|
$4,623 | — | 31 Dec 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
343
|
$2,497 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
302
|
$2,199 | — | 31 Dec 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
250
|
$2,000 | — | 31 Dec 2023 | |
| GAMMA Investing LLC |
13F
|
Company |
0%
|
175
|
$1,330 | — | 31 Dec 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
141
|
$1,026 | — | 31 Dec 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
33
|
$240 | — | 31 Dec 2023 |
Institutional Holders of Nanobiotix S.A. - Common Stock (NBTX) as of Q1 2024
As of 31 Mar 2024,
Nanobiotix S.A. - Common Stock (NBTX) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,306,982 shares.
The largest 10 holders included
JOHNSON & JOHNSON, BAILLIE GIFFORD & CO, PERCEPTIVE ADVISORS LLC, BlackRock Inc., UBS Group AG, GAMMA Investing LLC, Qube Research & Technologies Ltd, Tower Research Capital LLC (TRC), BANK OF AMERICA CORP /DE/, and RHUMBLINE ADVISERS.
This page lists
11
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
12
Q1 2024 holders
11
Holder diff
-1
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.